Rac mediates TNF-induced cytokine production via modulation of NF-κB

被引:85
作者
Williams, Lynn A. [1 ]
Lali, Ferdinand [1 ]
Willetts, Kate [1 ]
Balague, Cristina [2 ]
Godessart, Nuria [2 ]
Brennan, Fionula [1 ]
Feldmann, Marc [1 ]
Foxwell, Brian M. J. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, London W6 8LH, England
[2] Almirall Res Ctr, Dept Biol, Barcelona, Spain
基金
英国医学研究理事会;
关键词
TNF; IL-6; Rac; MAPK and NF-kappa B;
D O I
10.1016/j.molimm.2007.12.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
TNF is a key factor in a variety of inflammatory diseases. Here we report that TNF induced pro-inflammatory cytokine synthesis of IL-6 and IL-8 is mediated by the Rho GTPase Rac. TNF induces p42/p44, p54 and p38 MAPK kinase; these kinases have been implicated in control of cytokine synthesis. However, over-expression of a dominant negative form of Rac strongly inhibited TNF-induced p42/44 MAPK kinase activation, but had little effect upon JNK and no effect upon p38 MAPK activity. Another key signalling pathway controlling cytokine expression is NF-kappa B. When analyzing TNF-induced NF-kappa B activity via luciferase-reporter assays or via EMSA, we were able to show that the dominant negative version of Rac could completely abrogate TNF-induced NF-kappa B activity. In addition, we also observed that inhibition of the ERK pathway led to a reduction in TNF-induced NF-kappa B transcriptional activity; this was accompanied by an ablation of TNF-induced p65 phosphorylation at serine 276. This would suggest that TNF-induced activation of Rac, lies upstream of NF-kappa B activation, and that the inhibition of this pathway results in inhibition of cytokine production. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2446 / 2454
页数:9
相关论文
共 42 条
[1]
Signalling pathways of the TNF superfamily: A double-edged sword [J].
Aggarwal, BB .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (09) :745-756
[2]
Toll-like receptor 2-mediated NF-κB activation requires a RacI-dependent pathway [J].
Arbibe, L ;
Mira, JP ;
Teusch, N ;
Kline, L ;
Guha, M ;
Mackman, N ;
Godowski, PJ ;
Ulevitch, RJ ;
Knaus, UG .
NATURE IMMUNOLOGY, 2000, 1 (06) :533-540
[3]
BUTLER DM, 1988, J RHEUMATOL, V15, P1463
[4]
Rac1 and superoxide are required for the expression of cell adhesion molecules induced by tumor necrosis factor-α in endothelial cells [J].
Chen, XL ;
Zhang, Q ;
Zhao, R ;
Ding, XY ;
Tummala, PE ;
Medford, RM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (02) :573-580
[5]
THE SMALL GTP-BINDING PROTEINS RAC1 AND CDC42 REGULATE THE ACTIVITY OF THE JNK/SAPK SIGNALING PATHWAY [J].
COSO, OA ;
CHIARIELLO, M ;
YU, JC ;
TERAMOTO, H ;
CRESPO, P ;
XU, NG ;
MIKI, T ;
GUTKIND, JS .
CELL, 1995, 81 (07) :1137-1146
[6]
Anti-TNF therapy: Where have we got to in 2005? [J].
Feldmann, M ;
Brennan, FM ;
Foxwell, BMJ ;
Taylor, PC ;
Williams, RO ;
Maini, RN .
JOURNAL OF AUTOIMMUNITY, 2005, 25 :26-28
[7]
Feldmann M, 2001, ADV EXP MED BIOL, V490, P119
[8]
Stimulation of NFκB activity by multiple signaling pathways requires PAK1 [J].
Frost, JA ;
Swantek, JL ;
Stippec, S ;
Yin, MJ ;
Gaynor, R ;
Cobb, MH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (26) :19693-19699
[9]
Missing pieces in the NF-κB puzzle [J].
Ghosh, S ;
Karin, M .
CELL, 2002, 109 :S81-S96
[10]
Signaling to NF-κB [J].
Hayden, MS ;
Ghosh, S .
GENES & DEVELOPMENT, 2004, 18 (18) :2195-2224